The global recombinant DNA vaccine market is anticipated to grow at a significant CAGR of 11.7% during the forecast period (2022-2028). Recombinant DNA vaccine is used to develop antigens for many different pathogens, such as influenza, HIV, malaria, TB, and leishmaniasis, leading to the induction of immune responses against these etiologic agents in several animal […]
